Figure 4: Activities Key - PowerPoint PPT Presentation
1 / 1
Title:
Figure 4: Activities Key
Description:
... This includes chemical, biological and radiopharmaceutical substances that have not been previously available for therapeutic use in humans to be used for the ... – PowerPoint PPT presentation
Number of Views:12
Avg rating:3.0/5.0
Title: Figure 4: Activities Key
1
The percentage of NASs approved by CDER by
one-cycle review process has increased
Median approval time of NASs approved by
one-cycle review
Percentage of NASs approved by one-cycle review
according to priority designation
CDER United States Food and Drug Administration
Center for Drug Evaluation and Research NASs
new active substances.
Recommended
CrystalGraphics Presentations
